Middle-high risk endometrial cancer
Showing 1 - 25 of >10,000
Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis Trial in Shanghai (sentinel lymph node sampling
Recruiting
- Middle-high Risk Endometrial Cancer
- +2 more
- sentinel lymph node sampling (SLN)
- pelvic lymphonodectomy (PLN)
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 24, 2022
Cancer Screening Trial (transvaginal ultrasound and microscale endometrial sampling biopsy)
Not yet recruiting
- Cancer Screening
- transvaginal ultrasound and microscale endometrial sampling biopsy
- (no location specified)
Nov 5, 2023
Endometrial Cancer Trial in Oklahoma City (Pembrolizumab, Vaginal cuff brachytherapy (VCB), Paclitaxel)
Recruiting
- Endometrial Cancer
- Pembrolizumab
- +3 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 9, 2023
Endometrial Tumors Trial in Beijing (no intervention)
Recruiting
- Endometrial Neoplasms
- no intervention
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 22, 2022
Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes Trial in New York
Recruiting
- Colorectal Cancer
- +2 more
-
New York, New YorkNYP/Weill Cornell Medicine
Oct 17, 2023
Predictors of Node Positivity in Endometrial Cancer
Not yet recruiting
- Endometrial Cancer
- (no location specified)
Mar 29, 2023
Liquid Biopsies and Tumor Molecular Profiling in Predicting
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +5 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Endometrial Malignancy in Breast Cancer or Without AUB
Completed
- Endometrial Neoplasms
- Ultrasound
- Hysteroscopy
-
Bologna, Italy
- +3 more
Aug 3, 2023
Endometrial Cancer Trial in Hong Kong (Olaparib)
Not yet recruiting
- Endometrial Cancer
-
Hong Kong, Hong KongThe University of Hong Kong
Apr 2, 2022
Endometrial Cancer Trial in Chapel Hill (HIIT exercise)
Recruiting
- Endometrial Cancer
- HIIT exercise
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Feb 2, 2023
Circulating Tumor DNA Study in Patients With Endometrial Cancer
Recruiting
- Endometrial Cancer
- Whole blood
-
Paris, FranceHôpital Cochin
Jul 12, 2023
Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United
Active, not recruiting
- Endometrial Clear Cell Adenocarcinoma
- +4 more
- Computed Tomography
- +5 more
-
Houston, Texas
- +6 more
Dec 5, 2022
Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)
Not yet recruiting
- Endometrial Cancer
- +2 more
- Niraparib oral capsule
- (no location specified)
Oct 31, 2022
Recurrence Among Low Risk Endometrial Cancer Patients
Recruiting
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
- Bilateral Salpingectomy with Oophorectomy
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Endometrial Cancer, Lymph Node Metastases Trial in Brazil (Sentinel Node Mapping, Lymphadenectomy)
Recruiting
- Endometrial Cancer
- Lymph Node Metastases
- Sentinel Node Mapping
- Lymphadenectomy
-
Curitiba, Parana, Brazil
- +4 more
Feb 16, 2022
Risk Factors for Endometrial Cancer in Black Women
Active, not recruiting
- Endometrial Cancer
- questionnaire administration
- +2 more
-
Bronx, New York
- +3 more
Aug 9, 2022
Prediction of Lymph Node Involvement in Endometrial Carcinoma
Completed
- Endometrial Cancer
- hysterectomy
-
Assiut, Cairo, EgyptAhmed Abbas
Aug 24, 2022
Endometrial Tumors Trial in Salt Lake City (Time Restricted Eating (TRE) Schedule)
Recruiting
- Endometrial Neoplasms
- Time Restricted Eating (TRE) Schedule
-
Salt Lake City, UtahHuntsman Cancer Institute
May 17, 2022
Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI
Not yet recruiting
- Cytoreductive Surgery
- +4 more
- PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2022
Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)
Not yet recruiting
- Prostate Cancer
- Newly-Diagnosed Prostate Cancer
- (no location specified)
Nov 3, 2023
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
Vaginal Estradiol Tablets and Endometrial Cancer Risk in
Completed
- Postmenopausal Vaginal Atrophy
- Vagifem®
- Non-Vagifem® LDVE, Estradiol
-
Soeborg, DenmarkNovo Nordisk Investigational Site
Jul 5, 2022